Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CATALYST Study: Catalyzing Access to New Prevention Products to Stop HIV

NCT05937698 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.

NCT NCT05937698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05937698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CATALYST Study: Catalyzing Access to New Prevention Products to Stop HIV
Lead sponsor
FHI 360
Phase
Observational
Overall status
Terminated
Start date
May 30, 2023
Completion date
January 27, 2025
Enrollment
6,069 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

hiv prevention